Abstract
Centrally acting cholinergic agents are currently reported to increase blood pressure in various species through the stimulation of muscarinic cholinoceptors. Moreover, several cardiovascular adverse effects have been reported from clinical studies. The aim of this study was to investigate the effects of tacrine, an acetylcholinesterase inhibitor which has been reported to have therapeutic potential in Alzheimer's disease, on blood pressure and two vasopressor systems (sympathetic and vasopressinergic) in Beagle dogs. Intravenous (i.v.) tacrine (2 mg kg(-1)) induced, in conscious and anesthetized dogs, an increase in systolic and diastolic blood pressure, accompanied by bradycardia. This increase was dose-dependent with a peak effect at 1.5 min following administration. Tacrine also induced an increase in noradrenaline, adrenaline and vasopressin plasma levels. Pretreatment with the muscarinic receptor antagonist, atropine (2 mg kg(-1), i.v.), abolished the pressor response to i.v. injection of tacrine while pretreatment with the peripheral muscarinic receptor antagonist, methylscopolamine (0.2 mg kg(-1), i.v.), did not alter the increase in blood pressure. Similarly, noradrenaline and adrenaline changes in plasma levels were n...Continue Reading
References
Apr 13, 1979·Brain Research·J J Buccafusco, H E Brezenoff
Dec 1, 1978·Neuropharmacology·M K Krstić
Jun 1, 1976·Japanese Journal of Pharmacology·H Ozawa, T Uematsu
Nov 26, 1991·European Journal of Pharmacology·S B LeeK W Sung
Jul 1, 1990·British Journal of Pharmacology·O RascolP Montastruc
Nov 13, 1986·The New England Journal of Medicine·W K SummersA Kling
Oct 1, 1988·Neuropharmacology·Y F Xiao, H E Brezenoff
Dec 1, 1987·Annals of Neurology·M M MesulamM A Morán
Jul 1, 1986·The American Journal of Psychiatry·J W Cain
Jun 5, 1986·European Journal of Pharmacology·A PazosJ M Palacios
Dec 1, 1974·European Journal of Pharmacology·H E Brezenoff, J Rusin
Sep 1, 1973·European Journal of Pharmacology·H E Brezenoff
Sep 1, 1984·The Journal of Physiology·G W Bisset, H S Chowdrey
Jan 1, 1982·Annual Review of Pharmacology and Toxicology·H E Brezenoff, R Giuliano
Aug 22, 1980·European Journal of Pharmacology·A P CaputiH E Brezenoff
Jan 1, 1995·Life Sciences·H HoriA Iguchi
Apr 24, 1995·Brain Research·A AllyJ H Mitchell
Nov 1, 1995·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·M H BassantY Lamour
May 13, 1995·Lancet·P Chrispin
May 1, 1994·Psychopharmacology·G GheusiR Dantzer
Dec 21, 1993·European Journal of Pharmacology·U OzkutluS Oktay
Sep 1, 1995·British Journal of Pharmacology·I H UlusB K Kiran
Oct 1, 1995·British Journal of Pharmacology·C BrefelO Rascol
Sep 1, 1955·British Journal of Pharmacology and Chemotherapy·V VARAGIC